Viking Therapeutics, Inc. SEC filings VKTX
Viking Therapeutics, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 22, 2014. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 1, 2026 | — |
| DEF 14A | Proxy statement | Apr 1, 2026 | May 19, 2026 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEFA14A | Additional proxy material | Apr 8, 2025 | — |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 20, 2025 |
| DEFA14A | Additional proxy material | Apr 5, 2024 | — |
| DEF 14A | Proxy statement | Apr 5, 2024 | May 21, 2024 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | — |
| DEFA14A | Additional proxy material | Apr 7, 2022 | — |
| DEF 14A | Proxy statement | Apr 7, 2022 | May 24, 2022 |
| DEFA14A | Additional proxy material | Apr 8, 2021 | — |
| DEF 14A | Proxy statement | Apr 8, 2021 | May 20, 2021 |
| DEFA14A | Additional proxy material | May 20, 2020 | — |
| DEFA14A | Additional proxy material | Apr 6, 2020 | — |
| DEF 14A | Proxy statement | Apr 6, 2020 | May 21, 2020 |
| DEFA14A | Additional proxy material | Apr 5, 2019 | — |
| DEF 14A | Proxy statement | Apr 5, 2019 | May 23, 2019 |
| DEFA14A | Additional proxy material | Apr 6, 2018 | — |
| DEF 14A | Proxy statement | Apr 6, 2018 | May 24, 2018 |
| DEFA14A | Additional proxy material | Apr 7, 2017 | — |
| DEF 14A | Proxy statement | Apr 7, 2017 | May 23, 2017 |
| DEFA14A | Additional proxy material | Apr 12, 2016 | — |
| DEF 14A | Proxy statement | Apr 12, 2016 | May 26, 2016 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VKTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1607678
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.